158 related articles for article (PubMed ID: 3840407)
21. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
[TBL] [Abstract][Full Text] [Related]
22. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Perri RT; Allen JI; Oken MM; Limas C; Kay NE
Med Pediatr Oncol; 1985; 13(3):122-5. PubMed ID: 3838792
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin's disease: controversies and challenges for the future.
Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
[No Abstract] [Full Text] [Related]
25. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
[TBL] [Abstract][Full Text] [Related]
26. MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.
Cimino G; Biti GP; Anselmo AP; Maurizi Enrici R; Bellesi GP; Bosi A; Cionini L; Mungai V; Papa G; Ponticelli P
J Clin Oncol; 1989 Jun; 7(6):732-7. PubMed ID: 2715803
[TBL] [Abstract][Full Text] [Related]
27. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
[TBL] [Abstract][Full Text] [Related]
28. Treatment of childhood Hodgkin's disease without radiotherapy.
van den Berg H; Zsiros J; Behrendt H
Ann Oncol; 1997; 8 Suppl 1():15-7. PubMed ID: 9187423
[TBL] [Abstract][Full Text] [Related]
29. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
Klimo P; Connors JM
Semin Hematol; 1988 Apr; 25(2 Suppl 2):34-40. PubMed ID: 2456621
[TBL] [Abstract][Full Text] [Related]
30. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
[TBL] [Abstract][Full Text] [Related]
31. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
Vuković I; Janković MB; Janić D; Stojimirović E
Srp Arh Celok Lek; 1985; 113(11-12):1013-21. PubMed ID: 3841764
[No Abstract] [Full Text] [Related]
32. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
33. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Longo DL; DeVita VT
Important Adv Oncol; 1992; ():155-65. PubMed ID: 1582671
[No Abstract] [Full Text] [Related]
34. Chemotherapy alone for the treatment of early-stage Hodgkin's disease.
Cimino G
Eur J Cancer; 1990; 26(11-12):1115-8. PubMed ID: 2149991
[No Abstract] [Full Text] [Related]
35. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
36. Combined-modality therapy for the treatment of Hodgkin's disease.
Hoppe RT
Front Radiat Ther Oncol; 1992; 26():172-80. PubMed ID: 1511919
[No Abstract] [Full Text] [Related]
37. The intergroup Hodgkin's disease in children. A study of stages I and II.
Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
[TBL] [Abstract][Full Text] [Related]
38. [Hodgkin's disease in children; treatment results with or without radiotherapy].
Behrendt H
Ned Tijdschr Geneeskd; 1986 May; 130(19):865-8. PubMed ID: 3754935
[No Abstract] [Full Text] [Related]
39. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW
Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
[No Abstract] [Full Text] [Related]
40. MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
Klimo P; Connors JM
J Clin Oncol; 1985 Sep; 3(9):1174-82. PubMed ID: 2411881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]